126 related articles for article (PubMed ID: 27863661)
1. Doxorubicin enhances curcumin's cytotoxicity in human prostate cancer cells in vitro by enhancing its cellular uptake.
Klippstein R; Bansal SS; Al-Jamal KT
Int J Pharm; 2016 Nov; 514(1):169-175. PubMed ID: 27863661
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells.
Sesarman A; Tefas L; Sylvester B; Licarete E; Rauca V; Luput L; Patras L; Banciu M; Porfire A
Pharmacol Rep; 2018 Apr; 70(2):331-339. PubMed ID: 29477042
[TBL] [Abstract][Full Text] [Related]
3. Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects.
Tang H; Murphy CJ; Zhang B; Shen Y; Sui M; Van Kirk EA; Feng X; Murdoch WJ
Nanomedicine (Lond); 2010 Aug; 5(6):855-65. PubMed ID: 20735222
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment.
Sesarman A; Tefas L; Sylvester B; Licarete E; Rauca V; Luput L; Patras L; Porav S; Banciu M; Porfire A
Drug Deliv Transl Res; 2019 Feb; 9(1):260-272. PubMed ID: 30421392
[TBL] [Abstract][Full Text] [Related]
5. Improved pharmacokinetics and reduced side effects of doxorubicin therapy by liposomal co-encapsulation with curcumin.
Sesarman A; Muntean D; Abrudan B; Tefas L; Sylvester B; Licarete E; Rauca V; Luput L; Patras L; Banciu M; Vlase L; Porfire A
J Liposome Res; 2021 Mar; 31(1):1-10. PubMed ID: 31631726
[TBL] [Abstract][Full Text] [Related]
6. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.
Wong HL; Rauth AM; Bendayan R; Manias JL; Ramaswamy M; Liu Z; Erhan SZ; Wu XY
Pharm Res; 2006 Jul; 23(7):1574-85. PubMed ID: 16786442
[TBL] [Abstract][Full Text] [Related]
7. Curcumin-albumin conjugates as an effective anti-cancer agent with immunomodulatory properties.
Aravind SR; Krishnan LK
Int Immunopharmacol; 2016 May; 34():78-85. PubMed ID: 26927614
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
9. Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo.
Al-Jamal KT; Al-Jamal WT; Wang JT; Rubio N; Buddle J; Gathercole D; Zloh M; Kostarelos K
ACS Nano; 2013 Mar; 7(3):1905-17. PubMed ID: 23527750
[TBL] [Abstract][Full Text] [Related]
10. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.
Jyoti K; Pandey RS; Kush P; Kaushik D; Jain UK; Madan J
Int J Biol Macromol; 2017 May; 98():50-58. PubMed ID: 28130133
[TBL] [Abstract][Full Text] [Related]
11. In vitro demonstration of enhanced prostate cancer toxicity: pretargeting with Bombesin bispecific complexes and targeting with polymer-drug-conjugates.
Patil V; Gada K; Panwar R; Majewski S; Tekabe Y; Varvarigou A; Khaw BA
J Drug Target; 2013 Dec; 21(10):1012-21. PubMed ID: 23863118
[TBL] [Abstract][Full Text] [Related]
12. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
Wang J; Ma W; Tu P
Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
Zeng X; Morgenstern R; Nyström AM
Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin encapsulated in micelles enhances radiosensitivity in doxorubicin-resistant tumor cells.
Xu W; Han M; Diao Y; Pan T; Ge W; Liu H; He H; Jiang H; Zheng S; Zhang S; Gao J; Wei Q
Discov Med; 2014 Oct; 18(99):169-77. PubMed ID: 25336030
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a new function of curcumin which enhances its anticancer therapeutic potency.
Nagahama K; Utsumi T; Kumano T; Maekawa S; Oyama N; Kawakami J
Sci Rep; 2016 Aug; 6():30962. PubMed ID: 27476814
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of doxorubicin-incorporated magnetic albumin nanospheres.
Zeybek A; Şanlı-Mohamed G; Ak G; Yılmaz H; Şanlıer ŞH
Chem Biol Drug Des; 2014 Jul; 84(1):108-15. PubMed ID: 24524300
[TBL] [Abstract][Full Text] [Related]
18. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model.
Liu CW; Xiong F; Jia HZ; Wang XL; Cheng H; Sun YH; Zhang XZ; Zhuo RX; Feng J
Biomacromolecules; 2013 Feb; 14(2):358-66. PubMed ID: 23286342
[TBL] [Abstract][Full Text] [Related]
19. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
20. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
